16 December 2025
Disclaimer: This is a simplified summary of a public company filing. See full disclaimer here.
YIJIA GROUP CORP.
CIK: 1699709•2 Annual Reports•Latest: 2025-07-24
10-K / July 24, 2025
Revenue:$2,662,105
Income:$850,746
10-K / July 29, 2024
Revenue:$570,694
Income:$140,865
10-K / July 24, 2025
Yijia Group Corp. - Company Summary
Business Activities
- Primary Business Operations:
- Provides management consulting services focused on funding and financial advisory for domestic and international clients.
- Markets and supplies healthcare products, particularly anti-aging products that increase NAD+ levels.
- Offers personalized health consultation and develops customized nutrition and wellness plans based on individual customer conditions and goals.
- Provides management, accounting, and financial advisory services to other businesses.
Revenue Streams
- Consulting Service Segment:
- Generates revenue through management, financial, and business consulting services.
- Recognizes revenue over the period services are provided.
- Healthcare Segment:
- Primarily earns revenue from sale of healthcare products, including NAD+ boosting supplements (e.g., Nicotinamide Riboside capsules).
- Recognizes revenue upon product delivery or customer pickup.
Financial Highlights (Year Ended April 30, 2025)
- Total Revenue: $2,662,105
- From healthcare product sales: $2,651,267
- Consulting services: $10,838
- Gross Profit: $1,575,710
- Net Income: $850,746
- Total Operating Expenses: $367,396
- Income from Operations: $1,208,314
Customer and Market Data
- Major customers are located in PRC (China), Hong Kong, and the USA.
- During 2025, customers accounting for 10% or more of revenue include:
- NOVA BIOLAB: $972,168 (37% of revenue)
- Wansushe NG International: $1,072,230 (40% of revenue)
- Tianjin Nuoan International Trade Co., Ltd: $374,880 (14% of revenue)
Employees
- Number of Employees: 1 full-time employee (officers and staff are ready to expand as needed).
Recent Organizational Changes
- The company was incorporated on January 25, 2017.
- Changed name to Yijia Group Corp. on November 15, 2018.
- Major shareholder Xianchang Ma acquired ~86.3% ownership in June 2023 but passed away in August 2023.
- Control transferred to his heir, Ms. Caihong Qu.
- Current management includes:
- Qiuping Lu: CEO, President, and Director.
- Ruiming Zhou: Director.
- Dr. Steven Niu: CFO.
Subsidiary
- Nutripeak Trading Corporation:
- Founded on November 9, 2023.
- Focused on marketing and supplying healthcare products.
- Fully owned (100 shares).
Additional Notes
- The company operates on a multi-channel marketing approach, including e-commerce, website, stores, social media, and direct sales.
- The company has no research and development costs and currently does not maintain insurance.
- Revenue growth was driven by increased sales of healthcare products, with a 366% increase from 2024 to 2025.
- The company has a small number of stockholders (62 as of July 17, 2025).
